New Delhi: Drug firm Wockhardt on Monday reported narrowing of consolidated net loss of ₹14.47 crore for the quarter ended March 2019.
The company had posted a net loss of ₹154.55 crore for the corresponding period of the previous fiscal, Wockhardt said in a filing to the BSE.
Consolidated revenue from operations of the company stood at ₹979.13 crore for the quarter under consideration. It was ₹1,018.26 crore for the corresponding period a year ago.
For the fiscal year ended March this year, its net loss stood at ₹194.53 crore as against ₹608.30 crore for the previous fiscal year.
Consolidated revenue from operations for the recently concluded fiscal year stood at ₹4,158.38 crore. It was ₹3,936.90 crore for the previous year.
Shares of Wockhardt closed at ₹408.65 per scrip on the BSE, up 0.41% from its previous close.